Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2024-10-22 Report Publication Anno…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA listed on Euronext Oslo Børs
Report Publication Announcement Classification · 1% confidence The document announces that Lifecare ASA has completed its transfer from Euronext Growth to the main list, Euronext Oslo Børs, and details the significance of this event, including management commentary. This is a corporate action announcement related to the company's listing status and market segment change. It is not a standard periodic financial report (10-K, IR, ER), a proxy statement (DEF 14A), or a specific transaction report (DIV, POS, DIRS). Since it is a formal announcement regarding a significant corporate event (listing change) that doesn't fit the specific categories like Capital/Financing Update (CAP) or Delisting (DLST), it best fits the general Regulatory Filings category (RNS) as a miscellaneous, non-standard regulatory announcement, or potentially a general corporate update. Given the context of a stock exchange listing change, RNS is the most appropriate fallback for a non-standard corporate event announcement.
2024-10-22 English
LIFE Lifecare ASA uplisting to Euronext Oslo Børs is approved
Delisting Announcement Classification · 1% confidence The document is a short announcement (2140 characters) regarding Lifecare ASA's successful uplisting from Euronext Growth to the regulated market, Euronext Oslo Børs, effective the next day. It details the approval and quotes the CEO about this milestone. This is a specific corporate action announcement related to the company's stock exchange listing status, not a full financial report (like 10-K or IR), a dividend notice, or an earnings release. Since there is no specific category for 'Listing Change Announcement', and it is a formal regulatory update about the company's securities trading venue, it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere. It is too specific for a general 'Share Issue/Capital Change' (SHA) as it concerns the market segment rather than the share count itself, and it is not a report publication announcement (RPA) as it is the primary announcement of the event, not just a notice that a report is available.
2024-10-21 English
LIFE Lifecare ASA uplisting to Euronext Oslo Børs is approved
Delisting Announcement Classification · 1% confidence The document announces that Lifecare ASA's uplisting to Euronext Oslo Børs has been approved and will take place on October 22, 2024. This is a corporate action related to the company's stock exchange listing status, which is a significant regulatory/market event. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a director's dealing (DIRS). It is a specific announcement regarding the company's listing status and market segment change. This type of announcement, which details a change in market structure or listing venue, fits best under the general 'Regulatory Filings' (RNS) category as it is a mandatory disclosure to the market that doesn't fit the more specific financial or governance codes. Given the short length and the nature of the announcement (a market event disclosure), RNS is the most appropriate general regulatory filing code.
2024-10-21 English
Lifecare ASA: Share capital increase registered
Capital/Financing Update Classification · 1% confidence The document is titled "LIFECARE ASA: SHARE CAPITAL INCREASE REGISTERED" and explicitly states that the share capital increase pertaining to the issuance of new shares from a recent offering has been registered with the Norwegian Register of Business Enterprises. It details the new share capital amount and the expected trading dates for the new shares. This directly relates to a change in the company's capital structure following a financing/issuance event. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions a previous announcement, the core content here is the final registration and confirmation of the capital change, not just an announcement of a report (RPA/RNS).
2024-10-18 English
Lifecare ASA: Share capital increase registered
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces that a 'Share capital increase registered' following a successful retail offering of new shares. It details the resulting new share capital amount and the expected delivery/tradability dates for the new shares. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not an earnings release, a full annual report, or a simple dividend notice.
2024-10-18 English
Lifecare ASA: Public retail offering successfully placed
Capital/Financing Update Classification · 1% confidence The document is an announcement titled "LIFECARE ASA: PUBLIC RETAIL OFFERING SUCCESSFULLY PLACED". It details the successful placement of new shares, the gross proceeds raised (NOK 16,625,320), allocation details, expected timelines for payment and delivery, and the resulting share capital structure. This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital event.
2024-10-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.